A new way for Filipinos to take control of their health
With rising healthcare costs and growing health concerns, more Filipinos are realizing that prevention truly is better than cure. In response, Manulife Philippines has teamed up with AMILI, Southeast Asia’s first microbiome insights company, to bring personalized gut microbiome screening to the country.
This innovation gives Filipinos access to science-backed tools that help them understand their gut health better empowering them to make informed lifestyle and nutrition choices for improved immunity, digestion, and overall well-being.
Why Gut Health Matters More Than Ever
A recent 2025 Asia Care Survey revealed that 82% of Filipinos worry about increasing healthcare costs, while many feel uncertain about maintaining both their physical and financial well-being. By offering microbiome testing designed for Asian populations, Manulife is giving customers a chance to take a proactive approach to health focusing on early detection and prevention instead of expensive treatments later on.
Science Meets Insurance: Manulife’s Next-Level Health Approach
Manulife Philippines President and CEO Rahul Hora shared that the partnership with AMILI represents a major step forward in redefining what health protection can mean for Filipinos.
“This collaboration allows us to go beyond traditional insurance by offering a unique, proactive health experience,” Hora said. “We want to empower our customers to make better health decisions through innovation and personalized care.”
Through the program, Manulife customers can access a personalized gut health screening, complete with nutrition recommendations and teleconsultations to help interpret results. These insights can improve not just digestion, but also immunity, mental health, heart function, and longevity.
Empowering Filipinos Toward Preventive Wellness
Grace Mallabo, Manulife Philippines’ Chief Health and Product Officer, emphasized that this initiative reinforces the company’s role as a true partner in health, not just a financial safety net.
“We’re giving Filipinos access to science-based tools and preventive care so they can make informed decisions and live better lives,” Mallabo said.
By integrating personalized insights into its services, Manulife aims to support longer, healthier lives for Filipinos, helping reduce the burden of medical costs in the long term.
AMILI’s Science-Backed Insights
AMILI’s testing is powered by the largest multi-ethnic gut microbiome database in Southeast Asia, offering insights into digestive health, immunity, mental wellness, and chronic disease prevention.
Dr. Jeremy Lim, AMILI’s CEO and Co-founder, expressed enthusiasm for expanding their reach through this partnership:
“We’re proud to support Manulife’s customers in the Philippines with actionable, science-backed insights. This is a big step toward making preventive care accessible across Southeast Asia,” he said.
Building a Healthier Future for Filipinos
This initiative expands on Manulife and AMILI’s First-in-Asia Gut Microbiome Screening, which first launched in Singapore in 2024. It’s part of Manulife’s broader commitment to making healthcare more personal and accessible through technology and innovation.
To learn more about Manulife’s wellness initiatives, visit manulife.com.ph/services/manulife-move.html.
Health Starts From Within
As Filipinos continue to juggle busy lifestyles, this collaboration reminds us that good health begins in the gut. Taking a simple microbiome test could be your first step toward a stronger immune system, sharper mind, and longer, healthier life.
If you’ve been meaning to prioritize your wellness, now’s the time to take charge, science and innovation are finally on your side.